Catalyst Wire Dossier Catalyst Wire Dossier

FOLFIRI regimen

irinotecan + leucovorin + 5-fluorouracil
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for FOLFIRI regimen, covering 2017-06-01 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer [Phase 2]

See pricing